The Cancer Letter

Inside information on cancer research and drug development

Vol.
18
No.
24
June 12, 1992Jun 12, 1992
Free
DOWNLOAD THE PDF

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

In Brief: Seffrin’s ACS Appointment Is Official; Liotta Selected As NIH; Strategic Plan Meetings

Other ASCO Plenary Papers: Long Awaited Chemotherapy Results

Congress Okays NIH Reauthorization, Allows NCI $472 Mil. More

Gallo Inquiry Complete; NCAB’s AIDS Committee Plans Q&A Session

NCAB Decides To End IGs, Review total Research Support, And Consider P01 Limitation

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account